UnknownNot Applicable

Triceps Surae Ultrasonographic Characteristics in Hemiparetic Stroke Survivors

Italy50 participantsStarted 2021-01-14

Plain-language summary

This study aims to evaluate, in hemiparetic patients, changes in muscle ultrasound structure about the focal treatment of spasticity with botulinum toxin type A. For this purpose, the analysis of the mean echo intensity will be carried out on ultrasound acquisitions, identifying the possible correlations between the muscle echogenicity, the variations in the pennation angle, and the length of the fascicles. For image processing operations, ImageJ software was applied.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * unilateral ischaemic or haemorrhagic stroke (documented with clinical examination and neuroradiological findings) * presence of spasticity at lower limb muscles, at least grade 1+ in the modified Ashworth Scale 3. * age ≥ 18 years Exclusion Criteria: * inability to walk before stroke * presence of severe cognitive impairment * presence of other musculoskeletal, neurological or cardiopulmonary impairment which can interfere with clinical findings * presence of skin lesions that can contraindicate BoNT-A treatment * previous surgical myotendinous elongation

What they're measuring

muscle structure variations

Timeframe: single measure through study completion (1 year)

Trial details

NCT IDNCT05097482

SponsorAlessio Baricich

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12-13

Contact for this trial

Alessio Baricich, MD PhD

03213734844 alessio.baricich@med.uniupo.it

View on ClinicalTrials.gov More Spastic Foot trials